Navigation Links
Confirmation of Bogoch Replikins Influenza Patents by Harvard-CDC and Scripps-Crucell Data
Date:3/20/2009

BOSTON, March 20 /PRNewswire/ -- Replikins, Ltd. announced today that data recently published from Harvard-CDC and Scripps-Crucell in Nature(1) and Science(2) confirms the 2001 discoveries by Dr. Samuel and Elenore Bogoch of peptides in the hemagglutinin unit of influenza, which they named Replikins, which are shared across flu strains, conserved over time, associated with the last three pandemics of 1918, 1957 and 1968, as well as current H5N1 outbreaks, and are the basis of broad spectrum flu vaccines. The Replikins sequences, as specified by the Bogoches, are the subject of granted patents from 2001 and a 2005 monograph(3).

The amino acid contact points between the neutralizing antibody and the virus that the Harvard-CDC and Scripps-Crucell investigators both observed, out of over 500 possible sites, are in the influenza Replikins. The confirming groups' data also verified the Bogoch 2001 findings of conservation of these very Replikins peptides over decades, and the sharing of Replikins between strains of influenza, making general flu vaccines possible for the first time.

The Replikins peptides, associated with rapid replication, are quantitatively trackable and predictive of the intensity, timing, and country of outbreak. The company's FluForecast(R) software has correctly predicted recent H5N1 outbreaks and the countries in which they were going to occur(4).

Replikins, which are quantitatively related to lethality in influenza and other infectious diseases, such as HIV, anthrax, and malaria, as well as cancer, and a range of animal diseases, are the subject of synthetic vaccines in development at the Company.

1. Sui, J. et al. "Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses." Nature Structural and Molecular Biology, published online: Feb. 22, 2009, doi:10.1038-nsmb.1566.

2. Ekeirt, D.C. et al. "Antibody Recogniti
'/>"/>

SOURCE Replikins, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA
2. Confirmation of HGT Business Day - 18th November 2008
3. ProtoKinetix Receives Independent Confirmation of AAGP Anti-Inflammatory Action
4. Confirmation of Strong Growth Over the First Half of 2008
5. Replikins Oral Vaccine Synthesized in 7 Days Protects 91% of Shrimp Against a Lethal Virus
6. Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries
7. Fraunhofer USA Center for Molecular Biotechnology Receives Gates Foundation Grant for Avian Influenza Vaccine Development
8. Seasonal Influenza Activity Increasing Across Europe - H3N2 Dominant Strain
9. Rising H9N2 Influenza Replikin Count Has Doubled That of H5N1
10. DaVita Launches Flu Fighter Program in Support of National Influenza Week
11. Novavax to Present Seasonal Influenza Data Results in an Investor Conference Call on December 11, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...NGAPORE, Dec. 2 S*BIO Pte Ltd toda...AK2 inhibitor, SB1518, at The American Society of ...ew Orleans. ,, Data will be presented on the cl...ial of SB1518 detailing its safety, tolerability a... in dose levels ranging from 100 to 600 mg. These ...
(Date:12/2/2009)... The Scientist, a leading scientific magazine...squo; Evolve “Intelligent” EMCCD camer...10 Innovations of 2009. , ...MCCD camera from Photometrics ®, a designer ... cameras for the life sciences, was ranked fourth ...
(Date:12/1/2009)...W YORK, Dec. 1 Reportlinker.com an...able in its catalogue: ,, Industrial Enzymes -...inker.com/p0164431/Industrial-Enzymes---A-Global-M... is an oligopoly with few strong players and a hos...ities. Keen competition and commoditization charac...
(Date:12/1/2009)...NGHAI, Dec. 1 /PRNewswire-Asia/ -- Shanghai ChemPa...a leading China-based Contract Research,Organizati...09 Deloitte,Technology Fast 50 China, ranking 3rd ...nies in China. The award is a testament to ChemPar...2006 to 2008. , The results of the 2009 D...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...e of 27% over Third Quarter 2007, - EPS of $0.55 ...ases of 21% and 24% over Third Quarter 2...ges of $37.8 million, Increase of 39% over ...ING, Md., Oct. 30 United,Therapeutics Corporation...perations for the quarter ended September 30, 2008...
...sition to Early Cardiovascular,Events in Asian Pop...netics,Inc. (Amex: ILI ), announced today that Ke...ic Officer, will present new research findings on,... Cardiovascular Genomics,and Atherosclerosis Sympo.... 1, 2008, at the Samsung Medical Center in Seoul,...
...Samadi, M.D., a world renowned urologic oncologist...iques, following an OR Live Webcast. His proprieta...sponsible for sexual function and continence. To d...rostate surgeries and the results are quite pleasi...w York, NY (PRWEB) October 30, 2008 -- Dr. David S...
Other Biology Technology:United Therapeutics Reports Third Quarter 2008 Financial Results 2United Therapeutics Reports Third Quarter 2008 Financial Results 3United Therapeutics Reports Third Quarter 2008 Financial Results 4United Therapeutics Reports Third Quarter 2008 Financial Results 5United Therapeutics Reports Third Quarter 2008 Financial Results 6Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium 2Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium 3Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium 4Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 2Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 3Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 4
(Date:12/1/2009)...LE, Calif., Dec. 1 GestureTek Inc.....0 - a turnkey, portable, plug and play interactiv...its, entertainment and touring promotions. Gesture...s in camera-enabled gesture recognition technology...inment systems. ,, Guaranteed for quality, the ...
(Date:12/1/2009)...te of Technology has been awarded a U.S. Air Force... energy harvesting and adaptive materials, and to ...sses of the modern warfighter. , The $10.5 mill...c/Organic Nanostructures and Improved Cognition (B...d Kenneth Sandhage, professors in Georgia Tech,s S...
(Date:12/1/2009)... Dec. 1 iQor, a global provider of...included in the 2009 InfoWorld 100 Awards Top 10... system, TeQ21. This was the first submission for ... this prestigious list of companies," said Vikas K...tely transforming the way we do business, allowing...
Breaking Biology News(10 mins):GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Joint Worldwide CEOs of Ogilvy Healthworld Named 54357 1Joint Worldwide CEOs of Ogilvy Healthworld Named 54357 2Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 54355 1Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 54355 2Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 54355 3New Published Diet Study Reveals Meal Replacements as Top Strategy for Weight Loss 54353 1New Published Diet Study Reveals Meal Replacements as Top Strategy for Weight Loss 54353 2
...g, Va. -- A new technology, using electric pulses ...iefs as one of seven key technological breakthroug...at moving the procedure to the marketplace. One o...y member of the Virginia TechWake Forest Universit...BES), received a $240,000 grant from the Wallace H...
..., Mich. Chronic hepatitis B infects 400 million p...three effective vaccines available, hepatitis B re...cially in Africa and other developing areas. The d...million deaths globally each year. , In many poo...the current vaccines are costly and hard to come b...
... A new study of transfer RNA, a molecule that del...y of the cell, challenges long-held ideas about th...he study, researchers report that the dual functio...for a protein, and adding a specific amino acid to...nated independently of one another. The new findin...
Other Biology News:Commercialization aim of grant supporting technology that destroys cancer cells 2Nano vaccine for hepatitis B shows promise for third world 2Nano vaccine for hepatitis B shows promise for third world 3Study reveals surprising details of the evolution of protein translation 2
Rat Anti-Mouse HAI-1 Ectodomain Monoclonal Antibody, Unconjugated, Clone 199732 from R&D Systems
Goat Anti-Human IL-29 / IFN-lambda 1 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Rabbit Anti-Rat Potassium Channel EAG-1 Antibody, Unconjugated from CHEMICON
Goat Anti-WIF-1 (N-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: